Pérez-Ferriols A, Barnadas M, Gardeazábal J, de Argila D, Carrascosa J M, Aguilera P, Giménez-Arnau A, Rodríguez-Granados T, de Gálvez M V, Aguilera J
Servicio de Dermatología, Hospital General Universitario de Valencia, Valencia, España.
Servicio de Dermatología, Hospital La Santa Creu i Sant Pau, Barcelona, España.
Actas Dermosifiliogr. 2017 Mar;108(2):132-139. doi: 10.1016/j.ad.2016.09.003. Epub 2016 Oct 25.
Solar urticaria is a chronic inducible urticaria also classified as an idiopathic dermatosis. The objective of this paper is to define the phenotypic characteristics of solar urticaria and to evaluate its incidence.
This was a retrospective multicenter study in which data were gathered on the epidemiology and clinical, photobiologic, laboratory, and therapeutic characteristics of solar urticaria.
A total of 224 patients (141 women and 83 men) were included from 9 photobiology units. The mean age of the patients was 37.9 years (range, 3-73 years). A history of atopy was detected in 26.7%, and the most common presentation was allergic rhinitis (16.5%). Clinical signs were limited to sun-exposed areas in 75.9% of patients. The light spectrum most commonly implicated was visible light only (31.7%), and in 21% of cases it was only possible to trigger solar urticaria with natural light. The treatments most widely used by photobiology experts were oral antihistamines (65.46%), followed by different forms of phototherapy (34%). Complete resolution was observed most often in patients with solar urticaria triggered exclusively by visible or natural light, with statistically significant differences with respect to other wavelengths (P<.05). No increase in the annual incidence of solar urticaria was observed.
We have presented the largest series of solar urticaria published to date. The epidemiological, clinical, and photobiologic findings confirm previously reported data, although there was a particularly high rate of negative phototests in our series. Reactivity exclusively to visible or natural light was associated with a higher probability of resolution. No increasing trend was observed in the annual incidence.
日光性荨麻疹是一种慢性诱发性荨麻疹,也被归类为特发性皮肤病。本文的目的是明确日光性荨麻疹的表型特征并评估其发病率。
这是一项回顾性多中心研究,收集了有关日光性荨麻疹的流行病学、临床、光生物学、实验室及治疗特征的数据。
来自9个光生物学单位的224例患者(141例女性和83例男性)被纳入研究。患者的平均年龄为37.9岁(范围为3至73岁)。26.7%的患者有特应性病史,最常见的表现是过敏性鼻炎(16.5%)。75.9%的患者临床症状局限于暴露于阳光的部位。最常涉及的光谱仅为可见光(31.7%),21%的病例仅用自然光就能诱发日光性荨麻疹。光生物学专家最常用的治疗方法是口服抗组胺药(65.46%),其次是不同形式的光疗(34%)。在仅由可见光或自然光诱发的日光性荨麻疹患者中,最常观察到完全缓解,与其他波长相比有统计学显著差异(P<0.05)。未观察到日光性荨麻疹年发病率增加。
我们呈现了迄今为止发表的最大系列的日光性荨麻疹研究。流行病学、临床及光生物学研究结果证实了先前报道的数据,尽管我们的系列研究中光试验阴性率特别高。仅对可见光或自然光有反应与更高的缓解概率相关。未观察到年发病率的上升趋势。